Thy-1-integrin interactions in cis and trans mediate distinctive signaling
Author
dc.contributor.author
Ping, Hu
Author
dc.contributor.author
Leyton Campos, Lisette
Author
dc.contributor.author
Hagood, James S.
Author
dc.contributor.author
Barker, Thomas H.
Admission date
dc.date.accessioned
2022-07-25T16:29:53Z
Available date
dc.date.available
2022-07-25T16:29:53Z
Publication date
dc.date.issued
2022
Cita de ítem
dc.identifier.citation
Frontiers in Cell and Developmental Biology June 2022 Volume 10 Article 928510
es_ES
Identifier
dc.identifier.other
10.3389/fcell.2022.928510
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/186937
Abstract
dc.description.abstract
Thy-1 is a cell surface glycosylphosphatidylinositol (GPI)-anchored glycoprotein that bears a broad mosaic of biological roles across various cell types. Thy-1 displays strong physiological and pathological implications in development, cancer, immunity, and tissue fibrosis. Quite uniquely, Thy-1 is capable of mediating integrin-related signaling through direct trans- and cis-interaction with integrins. Both interaction types have shown distinctive roles, even when interacting with the same type of integrin, where binding in trans or in cis often yields divergent signaling events. In this review, we will revisit recent progress and discoveries of Thy-1-integrin interactions in trans and in cis, highlight their pathophysiological consequences and explore other potential binding partners of Thy-1 within the integrin regulation/signaling paradigm.
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
Frontiers Media
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States